Also known as: Tata 1mg, Tata 1MG
Tata 1mg is India's leading digital consumer healthcare platform, offering e-pharmacy, online consultations, lab tests, and trusted health information. The platform aims to make healthcare understandable, accessible, and affordable.
Eli Lilly's weight-loss drug Mounjaro fueled sevenfold sales growth in Brazil and doubled sales in India within months of launch, as the company commits $1 billion to make India a global export hub for its supply chain.
Investigation reveals prescription-only weight-loss drugs Mounjaro and Wegovy are easily accessible in India without proper medical oversight, as semaglutide goes off-patent next month with prices expected to drop 70 percent.
